The proposed classification described here includes, step by step, the use of lipid analyses, lipoprotein analyses, and other clinical and biologic data. It provides an approach to the etiologic and to the pathogenic classification by which the former will ultimately be replaced. The classification for genetic purposes is based on the assumption that the patient has been on a standard diet prior to the analyses.
Hyperlipidemia
Cholesterol (Chol) and triglyceride (TG) analyses are the simplest means for detecting hyperlipoproteinemia. They also provide some information about the type of hyperlipoproteinemia because the proportion of these lipids varies from one lipoprotein family to another.
Knowledge of the concentrations of cholesterol and triglycerides permits the distinction of three general types of hyperlipidemia that roughly correspond to certain types of hyperlipoproteinemias:
(1) High cholesterol concentrations and normal triglyceride concentrations-this group, sometimes called "pure hypercholesterolemia," usually corresponds to hyper-,8-1ipoprotein-emia. (2) High triglyceride and normal cholesterol concentrations-this group usually corresponds to either "pure hyperchylomicronemia" or hyperpre-/3-lipoproteinemia.
(3) High cholesterol and high triglyceride concentrations-all of the major types of hyperlipoproteinemia, except "pure" hyper-,3-lipoproteinemia, may occur in this group.
The heterogeneity of the third group particularly emphasizes the need for a classification based on lipoproteins.
It is possible to refine a little the classifications of hyperlipidemias by adding a total phospholipid (PL) measurement and also by calculating the following ratios: Chol/TG and Chol/PL.
The ratio Chol/TG indicates vhether the predominant elevation is in cholesterol or in triglyceride. The ratio Chol/PL often indicates elevation of HDL (a-lipoproteins) when it falls under 0.5. These refinements are not necessary to detect hyperlipidemia but do offer some assistance in classification if lipoproteins are not determined.
Hyperlipoproteinemia
Hyperlipidemia can usually be resolved into one of the abnormal lipoprotein patterns summarized in table 1. For the sake of simplicity, these patterns or types can be numbered according to the system of Fredrickson and his colleagues. These patterns are not to be equated with single diseases and each may have multiple causes. Most, but not all, hyperlipidemia is represented by the six (pre-,3) . This is partly due to the difficulty of separating these two lipoprotein families. The amount of excess VLDL, however, is always far less than the overwhelming amount of chylomicrons. Note. For some purposes it may be convenient to distinguish between two subtypes of this pattern. These are referred to here as lla and lIb. In both, the criterion for type II, an increase in LDL (,/3), is present, but in one (IIb) an increase in VLDL (pre-,8 ) is also present. Recognition of Ilb is important because it may require treatment additional to that required for "pure" hypercholesterolemia. Both patterns may occur in the same kindreds affected with familial hyper-/3-lipoproteinemia; it is mainly for this reason that they must at present be considered under the main rubric of type II.
Type Ila Criteria
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Methods of Diagnosis
(1) Standing plasma clear (very helpful; not always diagnostic).
(2) Plasma cholesterol usually increased; plasma triglycerides normal; Chol/TG always > 1.5. The combination of preparative ultracentrifugation and electrophoresis described above may be augmented by a measurement of cholesterol and triglycerides in the VLDL (density < 1.006) ultracentrifuge fraction (the latter may possibly be substituted for the former). Normally, the Chol/TG ratio in VLDL is 0.2 or less. Significantly higher ratios ( >0.4) are indicative of type III (probably diagnostic).
Comment. The type III anomaly indicates the presence of abnormal VLDL or, more precisely, of abnormal LDL in the VLDL fraction of plasma lipoproteins. It may be suspected from a Chol/TG ratio of 1, especially when repeated analyses show marked lability of both Chol and TG concentrations, and a "broad 83', band appears on conventional electrophoresis. This combination may permit a presumptive diagnosis; however, the diagnosis should never be made alone from conventional electrophoresis on a single medium.
The definitive test is the demonstration of "floating /,," but an analysis of equivalent value may prove to be the measurement of cholesterol and triglyceride in VLDL; combining electrophoresis on PGE and one other medium permits a presumptive diagnosis. A simpler, accurate diagnostic test is still desired.
Recommended Tests
When the plasma Chol/TG ratio is close to 1 and a "broad /3" band is suspected on electrophoresis:
Circulation, Volume XLV, February 1972 (1) Plasma lipoprotein patterns obtained on polyacrylamide gel and on either paper, agarose, or cellulose acetate should be compared. Absence of /3-migrating lipoproteins on PGE and their presence on the other systems permits a presumptive diagnosis.
(2) When possible, confirmation of "floating /3" (or VLDL having a high Chol/TG ratio) should be made after preparative ultracentrifugation.
Type IV-Hyperpre-g-lipoproteinemia Criteria
(1) Increased VLDL (pre-,8 Volume XLV, February 1972 always used to assess pre-/3 concentrations with electrophoresis, and it is always elevated in type IV. Conversely, an apparent increase in pre-,8 lipoproteins on electrophoresis will not be accompanied by an increase in plasma TG if most of the pre-,8 represents "sinking pre-,/3 (see above). This is a normal phenome'ion and its frequent occurrence emphasizes the need for TG concentrations to monitor electrophoresis. One should look for signs of the "type III anomaly"; it is not necessary to exclude the anomaly by specific tests in most instances of type IV.
Recommended Tests
(1) For most samples, Chol plus TG plus observation of plasma plus electrophoresis permits a diagnosis.
(2) Estimate LDL and exclude type III in doubtful cases.
(3) The ultracentrifuge can be very helpful in certain cases.
Type V-Hyperpre-,3-lipoproteinemia and Chylomicronemia Criteria
(1) VLDL increased.
(2) Chylomicrons present.
Methods of Diagnosis
(1) Standing plasma-chylomicron ("cream") layer overlying a turbid infranatant layer (diagnostic, if type III anomaly is excluded).
(2) Plasma cholesterol increased; plasma triglyceride increased; plasma Chol/TG usually > 0.15 and <0.6 (helpful but not diagnostic).
(3) Electrophoresis-pre-,/ band is increased and frequently trails to origin where a distinct accentuation indicates concomitant presence of chylomicrons: /3-and a-lipoprotein bands are usually decreased, often markedly so. There is no "floating /3" (can be diagnostic, if trailing pre-,/ does not obscure a chylomicron band).
(4) Ultracentrifugation-chylomicrons and VLDL (Sf 20-400) increased. LDL, particularly subclass Sf 0-12, and HDL are usually decreased (diagnostic). Planar xanthomas occur with several kinds of hyperlipoproteinemia. In the familial disorders, they occur on the palms of the hands in type III and in homozygotes for type II.
They also may occur with obstructive liver disease. More widely distributed planar lesions, on the trunk and elsewhere, are rare and occur especially in hyperlipoproteinemia associated with dysglobulinemias.
Xanthelasma is frequent in type II and sometimes occurs in type III, but often may be seen in the absence of hyperlipidemia or hyperlipoproteinemia.
Arcus corneae (arcus senilis) is significant only when it appears before the age of 40 years. In younger people it usually implies familial type II hyperlipoproteinemia.
Other Clinical Signs
Pancreatitis or recurrent abdominal pain should lead to a suspicion of severe hyperglyceridemia (type I or V).
Family History
The family history often leads to the detection of hyperlipidemia: Ischemic heart disease and other vascular accidents in young relatives are usual in familial type II or type IV hyperlipoproteinemia.
Diabetes is often seen in families of patients with type IV or type V hyperlipoproteinemia, even if the patient himself is not the diabetic.
Other Useful Laboratory Data These include some common laboratory tests, such as those for: thyroid function, glucose tolerance, urinary protein, plasma protein electrophoresis, immunoglobulin quantification, liver function, and uric acid.
Certain special analyses may also be useful and include: plasma postheparin lipolytic activity, proportion of plasma cholesterol in the esterified form, lecithin cholesterol acyltransferase activity (LCAT), fat tolerance, and vitamin A tolerance.
Etiology of Hyperlipoproteinemia
Once the type pattern of hyperlipoproteinemia has been established, it is necessary to consider etiology. One approach is to consider etiology as falling into two main categories, secondary and primary hyperlipoproteinemias.
Secondary to Known Diseases
Common diseases that are often associated with hyperlipoproteinemia and that must always be excluded in considering etiology are: (1) hypothyroidism, (2) 
